Endpoints News’ Post

For the last few months, our team at Endpoints News has been looking over dozens of new #startups to find the ones we think are pursuing the most interesting scientific ideas, backed with the right financing and the smart leadership that can create the #biotech breakthroughs of tomorrow. The result is our annual Endpoints 11 list, which we’ll unveil in Boston on Sept. 26. The gala isn’t just a chance to meet and mingle with some of the most exciting companies in the industry — we’ll also be sitting down for a conversation with legendary researcher and Moderna co-founder Bob Langer for a one-on-one conversation. Getting picked as one of this year’s 11 companies isn’t a guarantee of success: We look for big bets that will change the lives of patients if they succeed, but might create some major fallout if they fail. But we’ve got a good track record. Of the 55 companies we’ve put on our list since 2018, more than a third have IPO’d, been acquired or brought drugs to market. I hope you’ll join us. Get your ticket (save 10% by using the code 10EDIT), and say hello to me and the other members of our newsroom. It’s going to be a great evening!